This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2011-2014.
Location History:
- Goesan-gun, KR (2011)
- Daejeon, KR (2014)
Company Filing History:
Years Active: 2011-2014
Title: Dae Seop Shin: Innovator in Pharmaceutical Composition
Introduction
Dae Seop Shin is a notable inventor based in Goesan-Gun, South Korea. He has made significant contributions to the field of pharmaceutical compositions, particularly in the development of compounds that target angiogenesis-related diseases. With a total of 2 patents, his work is paving the way for innovative treatments in cancer therapy and other related conditions.
Latest Patents
One of his latest patents is titled "Composition comprising benproperine derivatives as active ingredients for preventing and treating angiogenesis-related diseases." This invention focuses on a novel pharmaceutical composition that utilizes benproperine derivatives to inhibit cancer cell migration and the angiogenesis of vascular endothelial cells. The implications of this work are profound, as it can be effectively used not only as an anticancer agent but also for preventing and treating diseases caused by abnormal angiogenesis, such as diabetic retinopathy and corneal transplant rejection.
Another significant patent is for "Cinnamaldehyde derivatives having improved solubility in water, a method for preparing the same and a pharmaceutical composition comprising the same." This patent discloses a novel cinnamaldehyde compound that exhibits improved solubility in water and has inhibitory effects on cancer cell growth. The compound induces cell cycle arrest and cell death, making it a promising candidate for anticancer compositions.
Career Highlights
Dae Seop Shin is affiliated with the Korea Research Institute of Bioscience and Biotechnology, where he conducts his research and development activities. His work is characterized by a strong focus on creating effective pharmaceutical solutions that address critical health issues.
Collaborations
He collaborates with esteemed colleagues, including Byoung Mog Kwon and Dong Cho Han, to further enhance the impact of his research. Their combined expertise contributes to the advancement of innovative treatments in the pharmaceutical field.
Conclusion
Dae Seop Shin's contributions to pharmaceutical compositions are noteworthy, particularly in the context of treating angiogenesis-related diseases. His innovative patents reflect a commitment to improving health outcomes through scientific research and collaboration.